RecruitingPhase 3NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Sponsor: Eidos Therapeutics, a BridgeBio company
Jacksonville, FL · Miami, FL · Weston, FL · +37 more sites